All sponsors

Eli Lilly and Company $LLY

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS145
PHASE 3 / 2-394
RECRUITING73
READOUTS ≤12 MONTHS45
READOUT SLIPPED >6 MO38%

Delay Index: of 98 active trials registered more than a year ago, 37 have moved their primary completion (readout) date by more than 6 months since first registration (median +1.2 months). See all sponsors →

Open Eli Lilly and Company on the live radar map → 📅 $LLY readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
120 mg LY2784544
NCT01594723
P2Active, not recruitingNeoplasms, Hematologic1102015-03-20 (+5 mo)
MONARCH 3
NCT02246621
P3Active, not recruitingBreast Cancer4932017-01-31 (-5 mo)
MONARCH 2
NCT02107703
P3Active, not recruitingBreast Neoplasms6692017-02-14
JUNIPER
NCT02152631
P3Active, not recruitingNon Small Cell Lung Cancer4532017-09-15 (+14 mo)
Ramucirumab
NCT02711553
P2Active, not recruitingBiliary Tract Cancer; Metastatic Cancer3092018-02-16 (+2 mo)
RELAY
NCT02411448
P3Active, not recruitingMetastatic Non-Small Cell Lung Cancer5452019-01-23 (+6 mo)
MONARCH plus
NCT02763566
P3Active, not recruitingBreast Cancer4632019-03-29 (-8 mo)
monarchE
NCT03155997
P3Active, not recruitingBreast Cancer56372020-03-16 (-27 mo)
LIBRETTO-321
NCT04280081
P2Active, not recruitingSolid Tumor; Medullary Thyroid Cancer772021-03-25 (-2 mo)
Donanemab
NCT04437511
P3Active, not recruitingAlzheimer Disease17362023-04-14 (+1 mo)
LIBRETTO-431
NCT04194944
P3Active, not recruitingNon-Small Cell Lung Cancer2612023-05-01 (-7 mo)
Baricitinib
NCT04088409
P3Active, not recruitingUveitis302023-07-17 (+16 mo)
CYCLONE 2
NCT03706365
P2/3Active, not recruitingProstate Cancer3932024-01-02 (+28 mo)
postMONARCH
NCT05169567
P3Active, not recruitingBreast Neoplasm; Neoplasm Metastasis3682024-02-08 (+6 mo)
CYCLONE 3
NCT05288166
P3Active, not recruitingProstatic Neoplasms; Neoplasm Metastasis9252024-02-15 (-20 mo)
Ixekizumab
NCT04527380
P3Active, not recruitingJuvenile Psoriatic Arthritis; Enthesitis Related Arthritis1012024-02-19 (+11 mo)
Donanemab
NCT05738486
P3Active, not recruitingAlzheimer's Disease; Dementia11752024-05-16 (+2 mo)
EMBER-3
NCT04975308
P3Active, not recruitingBreast Neoplasms; Neoplasm Metastasis8742024-06-24 (+15 mo)
LIBRETTO-121
NCT03899792
P1/2Active, not recruitingMedullary Thyroid Cancer; Infantile Myofibromatosis362024-11-08 (+36 mo)
VIVID-2
NCT04232553
P3Active, not recruitingCrohn's Disease9962024-11-28 (+13 mo)
Abemaciclib
NCT05440786
P2Active, not recruitingSarcoma, Ewing; Neoplasm Metastasis462025-01-15 (-2 mo)
LIBRETTO-001
NCT03157128
P1/2Active, not recruitingNon-Small Cell Lung Cancer; Medullary Thyroid Cancer8572025-02-14 (+66 mo)
ATTAIN-1
NCT05869903
P3Active, not recruitingObesity; Overweight31272025-07-25 (-2 mo)
REBUILD-1
NCT03432286
P3Active, not recruitingEpisodic Migraine5332025-11-14 (+47 mo)
REBUILD-2
NCT04616326
P3Active, not recruitingChronic Migraine3122025-12-10 (+34 mo)
Tirzepatide
NCT06037252
P2Active, not recruitingType 2 Diabetes; Obesity4142026-01-08 (+12 mo)
LIBRETTO-432
NCT04819100
P3Active, not recruitingCarcinoma, Non-Small-Cell Lung1522026-01-12 (-63 mo)
ADorable-1
NCT05559359
P3Active, not recruitingAtopic Dermatitis; Eczema3772026-01-14 (+17 mo)
Bimagrumab
NCT06643728
P2Active, not recruitingObesity; Overweight2522026-01-16 (+4 mo)
Mirikizumab
NCT03519945
P3Active, not recruitingUlcerative Colitis10582026-03-04 (+30 mo)
Tirzepatide
NCT06075667
P3Active, not recruitingObesity; Overweight1602026-06-02 (+4 mo)
Eltrekibart
NCT06598943
P2Active, not recruitingUlcerative Colitis; Ulcerative Colitis Chronic1432026-08-03 (-16 mo)
Retatrutide
NCT06260722
P3Active, not recruitingDiabetes Mellitus, Type 212502026-08-27 (-3 mo)
Baricitinib
NCT04088396
P3Active, not recruitingSystemic Juvenile Idiopathic Arthritis582026-10 (+48 mo)
LY3650150
NCT06339008
P3Active, not recruitingPerennial Allergic Rhinitis (PAR)4502026-10-22 (+17 mo)
Retatrutide
NCT06297603
P3Active, not recruitingType 2 Diabetes3202026-10-26 (+1 mo)
LY4515100
NCT07511816
P2RecruitingAcute Pain; Molar2122026-11
TRIUMPH-5
NCT06662383
P3Active, not recruitingObesity8002026-11 (-5 mo)
LY3938577
NCT07215312
P2Active, not recruitingDiabetes Mellitus, Type 21002026-11
SURPASS-T1D-1
NCT06914895
P3Active, not recruitingType 1 Diabetes; Obesity9052026-11 (-6 mo)
SURPASS-T1D-2
NCT06962280
P3Active, not recruitingType 1 Diabetes; Obesity4652026-11 (-5 mo)
LY3537021
NCT07169851
P2RecruitingNausea; Vomiting2042026-12 (+3 mo)
RENEW-Smk-1
NCT07223840
P2RecruitingSmoking2222027-02
Abemaciclib
NCT06413706
P2Active, not recruitingGlioma452027-02 (-5 mo)
ADVANCE
NCT06672549
P3RecruitingObesity; Overweight1252027-02
SOLARIS-1
NCT07269210
P2RecruitingSevere Hypertriglyceridemia602027-03
Macupatide
NCT07215559
P2Active, not recruitingObesity; Overweight2002027-03
OA07
NCT07641517
P2RecruitingOsteoarthritis, Knee; Chronic Pain1502027-04
LY3537982
NCT04956640
P1/2Active, not recruitingCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms5402027-04 (+42 mo)
CPMP
NCT05986292
P2RecruitingOsteoarthritis, Knee; Diabetic Neuropathic Pain100002027-04
BP07
NCT07641504
P2RecruitingChronic Pain; Low Back Pain1502027-04
ACHIEVE-RAM
NCT07613307
P3RecruitingDiabetes Mellitus, Type 2; Diabetes Melletus1302027-05
CLARITY-CRP
NCT07783802
P2RecruitingAtherosclerosis; Cardiovascular Disease1202027-05
LY4005130
NCT07533019
P2RecruitingVitiligo; Non-Segmental Vitiligo (NSV)662027-05
LY3650150
NCT06338995
P3RecruitingChronic Rhinosinusitis With Nasal Polyps (CRSwNP)5102027-05 (+17 mo)
TOPAZ-UC
NCT07186101
P2RecruitingUlcerative Colitis2522027-05
CAMPFIRE
NCT05999994
P2RecruitingNeoplasms; Child1052027-05 (+12 mo)
LY3457263
NCT06897475
P2RecruitingType 2 Diabetes2002027-05 (+5 mo)
Mirikizumab - Intravenous (IV)
NCT07483073
P2RecruitingColitis, Ulcerative; Crohn Disease602027-06
TRIUMPH-8
NCT07232719
P3Active, not recruitingObesity; Overweight2502027-06
LY4395089
NCT07483099
P2RecruitingCrohn Disease602027-06
LY4005130
NCT07533006
P2RecruitingAlopecia Areata652027-06
NP07
NCT07285018
P2RecruitingDiabetic Peripheral Neuropathic Pain1502027-07
RENEW-IBS-C
NCT07545772
P2RecruitingIrritable Bowel Syndrome; Constipation3422027-07
Orforglipron
NCT06993792
P3Active, not recruitingObesity; Overweight14002027-08 (+7 mo)
Orforglipron
NCT06972459
P3Active, not recruitingObesity; Overweight8002027-08 (+7 mo)
Orforglipron
NCT06972472
P3Active, not recruitingObesity; Overweight6002027-08 (+7 mo)
Orforglipron
NCT06948422
P3Active, not recruitingHypertension9742027-09
TRIUMPH-7
NCT07035093
P3Active, not recruitingObesity; Overweight5862027-09
LY3305677
NCT06143956
P2RecruitingObesity; Overweight14812027-09 (+33 mo)
RENEW-IBS-D
NCT07545759
P2RecruitingIrritable Bowel Syndrome; Diarrhea5312027-09
Macupatide
NCT07589608
P2RecruitingOverweight; Obesity4002027-09
Orforglipron
NCT06952530
P3Active, not recruitingHypertension4872027-09
Orforglipron
NCT06948435
P3Active, not recruitingHypertension; Overweight or Obesity4872027-09
SURMOUNT-MMO
NCT05556512
P3Active, not recruitingObesity; Overweight153742027-10
Tirzepatide
NCT06439277
P3RecruitingObesity; Weight Gain3002027-10 (+5 mo)
EMBER-4
NCT05514054
P3Active, not recruitingBreast Neoplasms80002027-10
RENEW-Scz-1
NCT07410507
P2RecruitingSchizophrenia4502027-11
Donanemab
NCT05026866
P3Active, not recruitingAlzheimer Disease29962027-11 (+1 mo)
SUNRAY-01
NCT06119581
P3RecruitingCarcinoma, Non-Small-Cell Lung; Neoplasm Metastasis12642027-11 (+13 mo)
Brenipatide
NCT07286175
P2RecruitingBipolar Disorder4002027-11
PIKALO-3
NCT07935317
P2Not yet recruitingBreast Neoplasms1202027-12
Dulaglutide
NCT06739122
P3RecruitingType 2 Diabetes552027-12 (+18 mo)
Orforglipron
NCT06672939
P3RecruitingObesity; Overweight1502027-12 (+10 mo)
AMAY
NCT05509777
P3RecruitingCrohn's Disease902027-12 (+17 mo)
ADorable-2
NCT05735483
P3Enrolling by invitationAtopic Dermatitis; Eczema3382027-12 (+17 mo)
LY4086940
NCT07890376
P2Not yet recruitingObesity; Overweight4602028-01
ENLIGHTEN-2
NCT07282600
P3RecruitingOverweight; Obesity10352028-01
Pirtobrutinib
NCT06721013
P1/2RecruitingImmune Thrombocytopenia (ITP)682028-02 (+12 mo)
RENEW-MDD-1
NCT07412756
P3RecruitingDepressive Disorder, Major10002028-02
RENEW-Op-1
NCT07420283
P2RecruitingOpioid Use Disorder4652028-03
BRAVE-AA-PEDS
NCT05723198
P3RecruitingAreata Alopecia; Alopecia5952028-03 (+35 mo)
ENLIGHTEN-4
NCT07353931
P3RecruitingOsteoarthritis; Overweight or Obesity9002028-03
ATTAIN-CN
NCT07790861
P3Not yet recruitingObesity; Overweight1922028-03
ENLIGHTEN-1
NCT07321886
P3RecruitingObesity; Overweight19802028-03
ENLIGHTEN-3
NCT07369011
P3RecruitingSleep Apnea, Obstructive; Obesity8002028-03
RESTRAIN-SUI
NCT07202884
P3RecruitingUrinary Incontinence,Stress10002028-03
RENEW-ALC-2
NCT07219953
P3RecruitingAlcohol Use Disorder11002028-04
TRIUMPH-6
NCT06859268
P3Active, not recruitingObesity6432028-04
RENEW-Asthma
NCT07219173
P2RecruitingAsthma5312028-04
RENEW-ALC-1
NCT07219966
P3RecruitingAlcohol Use Disorder11002028-04
COMMIT-UC
NCT06937086
P3RecruitingUlcerative Colitis; Obesity or Overweight3502028-04
ATTAIN-OA PAIN
NCT07153471
P3Active, not recruitingOsteoarthritis8002028-04
Donanemab
NCT05508789
P3Active, not recruitingAlzheimer Disease; Dementia15002028-05 (+34 mo)
RENEW-COPD
NCT07759245
P2RecruitingPulmonary Disease, Chronic Obstructive6062028-05
COMMIT-CD
NCT06937099
P3RecruitingCrohn's Disease; Obesity or Overweight2902028-05
RENEW-MDD-3
NCT07928245
P2Not yet recruitingMajor Depressive Disorder3302028-05
ENLIGHTEN-6
NCT07392190
P3RecruitingOverweight; Obesity9002028-06
ATTAIN-PAD
NCT07223593
P3RecruitingPeripheral Arterial Disease12052028-06
FORAY
NCT07827612
P2Not yet recruitingUrinary Bladder Neoplasms; Urologic Neoplasms1612028-07
Baricitinib
NCT07222332
P3RecruitingDiabetes Mellitus, Type 13002028-07
Donanemab
NCT07589595
P2RecruitingCognitive Dysfunction; Lewy Body Disease3502028-08
TRIUMPH-9
NCT07357415
P3Active, not recruitingObesity; Overweight6002028-10
AAVAnc80-hOTOF via Akouos Delivery Device
NCT05821959
P3RecruitingSensorineural Hearing Loss, Bilateral482028-10 (+6 mo)
Olomorasib
NCT07814417
P2Not yet recruitingColorectal Neoplasms502028-11
FRAmework-01
NCT07213804
P3RecruitingOvarian Neoplasms; Fallopian Tube Neoplasms16302028-11 (+7 mo)
RENEW-MDD- 2
NCT07775300
P3RecruitingDepressive Disorder, Major10002028-12
preEMBER
NCT07287098
P2RecruitingBreast Neoplasms6002029-01
Retatrutide
NCT06383390
P3Active, not recruitingAtherosclerotic Cardiovascular Disease (ASCVD); Chronic Kidney Disease (CKD)100002029-02
Lepodisiran Sodium
NCT06292013
P3Active, not recruitingAtherosclerotic Cardiovascular Disease (ASCVD); Elevated Lp(a)173002029-03
Remternetug
NCT06653153
P3Active, not recruitingAlzheimer's Disease14002029-04
LY4064809
NCT07174336
P3RecruitingBreast Neoplasms; Neoplasm Metastasis8002029-05
SUNRAY-02
NCT06890598
P3RecruitingCarcinoma, Non-Small-Cell Lung7002029-05 (+12 mo)
ACTIVATE-HFpEF
NCT07920887
P2Not yet recruitingHeart Failure, Diastolic; Diastolic Heart Failure5402029-07
AAVAnc80-antiVEGF via Akouos Delivery Device
NCT06517888
P1/2RecruitingVestibular Schwannoma272029-08
ATTAIN-NOW
NCT07794579
P3RecruitingOverweight; Prediabetic State20012029-08
Donanemab
NCT07602582
P3RecruitingAlzheimer Disease; Dementia5502029-09
FORAGER-2
NCT07218380
P3RecruitingCarcinoma, Transitional Cell; Urinary Bladder Neoplasms4502029-10
AMPLIFY-2
NCT07881458
P3RecruitingObesity; Overweight10002029-10
AMPLIFY-1
NCT07881432
P3Not yet recruitingObesity21152029-10
ENLIGHTEN-10
NCT07900633
P3Not yet recruitingObesity; Overweight30002029-11
ACCLAIM-CTA
NCT07613294
P3RecruitingAtherosclerosis; Cardiovascular Diseases2522029-12
Tirzepatide
NCT07817875
P3RecruitingObesity1502029-12
ACHIEVE-PEDS
NCT07668336
P3RecruitingDiabetes Mellitus, Type 21702030-03
Donanemab
NCT07571161
P3RecruitingAlzheimer Disease1402030-04
Pirtobrutinib
NCT07162181
P2Active, not recruitingLymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell132030-05
EMERALD-3
NCT07415044
P2RecruitingUlcerative Colitis (UC); Ulcerative Colitis, Active Moderate14312030-06
PIKALO-1
NCT05768139
P1/2RecruitingBreast Cancer; Solid Tumors, Adult8802030-07 (+49 mo)
Tirzepatide
NCT07165028
P3RecruitingMetabolic Dysfunction-Associated Steatotic Liver Disease45002030-08
SHINE-ON
NCT04844606
P3RecruitingUlcerative Colitis; Ulcerative Colitis Chronic1502030-12 (+38 mo)
MOVE-Lp(a)
NCT07157774
P3RecruitingElevated Lp(a); Atherosclerotic Cardiovascular Disease (ASCVD)104502031-03
JUVE-X
NCT03773965
P3RecruitingJuvenile Idiopathic Arthritis1902031-07 (+46 mo)
BARICADE-DELAY
NCT07222137
P3RecruitingDiabetes Mellitus, Type 11502031-07
Orforglipron
NCT07241390
P3RecruitingAtherosclerosis Cardiovascular Disease; Chronic Kidney Disease71402031-08
ANCHOR-AD
NCT07142954
P3RecruitingAlzheimer Disease34002033-07